The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The intranasal adjuvant Endocine™ enhances both systemic and mucosal immune responses in aged mice immunized with influenza antigen ; volume:14 ; number:1 ; day:3 ; month:3 ; year:2017 ; pages:1-6 ; date:12.2017
Virology journal ; 14, Heft 1 (3.3.2017), 1-6, 12.2017
- Creator
-
Falkeborn, Tina
- Contributor
-
Hinkula, Jorma
Olliver, Marie
Lindberg, Alf
Maltais, Anna-Karin
SpringerLink (Online service)
- DOI
-
10.1186/s12985-017-0698-4
- URN
-
urn:nbn:de:1111-20170326587
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Falkeborn, Tina
- Hinkula, Jorma
- Olliver, Marie
- Lindberg, Alf
- Maltais, Anna-Karin
- SpringerLink (Online service)
Other Objects (12)
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens
Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens
Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant
An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
Effect of mucosal adjuvant IL-1β on heterotypic immunity in a pig influenza model
A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma-irradiated influenza vaccine
Intranasal administration of cationic liposomes enhanced granulocyte–macrophage colony-stimulating factor expression and this expression is dispensable for mucosal adjuvant activity
Role of Adjuvant Treatment in Sinonasal Mucosal Melanoma
Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens
Intranasal administration with recombinant Bacillus subtilis induces strong mucosal immune responses against pseudorabies
Intranasal immunization with O-2′-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens
Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections